Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity
- 1 September 2005
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 15 (5) , 780-784
- https://doi.org/10.1111/j.1525-1438.2005.00136.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Expanded Experience With an Intradermal Skin Test to Predict for the Presence or Absence of Carboplatin HypersensitivityJournal of Clinical Oncology, 2003
- Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trialThe Lancet, 2003
- Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian CancerGynecologic Oncology, 2002
- Analysis of Patients with Epithelial Ovarian Cancer or Fallopian Tube Carcinoma Retreated with Cisplatin after the Development of a Carboplatin AllergyGynecologic Oncology, 2002
- Hypersensitivity Reactions to Carboplatin: To the EditorGynecologic Oncology, 2002
- Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic MalignanciesGynecologic Oncology, 2001
- Carboplatin hypersensitivity reactions in patients with ovarian and peritoneal carcinomaInternational Journal of Gynecologic Cancer, 1998
- Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinomaEuropean Journal Of Cancer, 1994
- Death from Anaphylaxis to Cisplatin: A Case ReportGynecologic Oncology, 1994
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990